Acetate and Butyrate Improve β-cell Metabolism and Mitochondrial Respiration under Oxidative Stress by Hu, Shuxian et al.
 
 
 University of Groningen
Acetate and Butyrate Improve β-cell Metabolism and Mitochondrial Respiration under
Oxidative Stress
Hu, Shuxian; Kuwabara, Rei; de Haan, Bart J; Smink, Alexandra M; de Vos, Paul
Published in:
International Journal of Molecular Sciences
DOI:
10.3390/ijms21041542
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Hu, S., Kuwabara, R., de Haan, B. J., Smink, A. M., & de Vos, P. (2020). Acetate and Butyrate Improve β-
cell Metabolism and Mitochondrial Respiration under Oxidative Stress. International Journal of Molecular
Sciences, 21(4), [1542]. https://doi.org/10.3390/ijms21041542
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
 International Journal of 
Molecular Sciences
Article
Acetate and Butyrate Improve β-cell Metabolism
and Mitochondrial Respiration
under Oxidative Stress
Shuxian Hu * , Rei Kuwabara, Bart J. de Haan, Alexandra M. Smink † and Paul de Vos †
Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen,
Hanzeplein 1, EA11, 9713 GZ Groningen, The Netherlands; r.kuwabara@umcg.nl (R.K.);
b.j.de.haan@umcg.nl (B.J.d.H.); a.m.smink@umcg.nl (A.M.S.); p.de.vos@umcg.nl (P.d.V.)
* Correspondence: s.hu@umcg.nl; Tel.: +31-(0)50-361-8043
† Shared last authorship.
Received: 30 January 2020; Accepted: 21 February 2020; Published: 24 February 2020


Abstract: Islet dysfunction mediated by oxidative and mitochondrial stress contributes to the
development of type 1 and 2 diabetes. Acetate and butyrate, produced by gut microbiota via
fermentation, have been shown to protect against oxidative and mitochondrial stress in many cell
types, but their effect on pancreatic β-cell metabolism has not been studied. Here, human islets and
the mouse insulinoma cell line MIN6 were pre-incubated with 1, 2, and 4 mM of acetate or butyrate
with and without exposure to the apoptosis inducer and metabolic stressor streptozotocin (STZ).
Both short-chain fatty acids (SCFAs) enhanced the viability of islets and β-cells, but the beneficial
effects were more pronounced in the presence of STZ. Both SCFAs prevented STZ-induced cell
apoptosis, viability reduction, mitochondrial dysfunction, and the overproduction of reactive oxygen
species (ROS) and nitric oxide (NO) at a concentration of 1 mM but not at higher concentrations.
These rescue effects of SCFAs were accompanied by preventing reduction of the mitochondrial fusion
genes MFN, MFN2, and OPA1. In addition, elevation of the fission genes DRP1 and FIS1 during STZ
exposure was prevented. Acetate showed more efficiency in enhancing metabolism and inhibiting
ROS, while butyrate had less effect but was stronger in inhibiting the SCFA receptor GPR41 and NO
generation. Our data suggest that SCFAs play an essential role in supporting β-cell metabolism and
promoting survival under stressful conditions. It therewith provides a novel mechanism by which
enhanced dietary fiber intake contributes to the reduction of Western diseases such as diabetes.
Keywords: acetate; butyrate; pancreatic β-cells; apoptosis; mitochondrial dynamics; oxygen
consumption rate
1. Introduction
Acetate and butyrate are short-chain fatty acids (SCFAs) and the main large intestinal microbiota
fermentation products of soluble fibers. SCFAs have been reported to attenuate various inflammatory
responses and metabolism disorders [1,2]. For example, acetate and butyrate have been shown to
reduce or delay the development of autoimmune diabetes by inhibiting proinflammatory lymphocytes
and supporting regulatory lymphocytes [3,4]. Furthermore, SCFAs are reported to promote insulin
sensitivity and metabolism in obese individuals by increasing fat oxidation, energy expenditure,
and decreasing lipolysis [5–8]. The effects of SCFA are not restricted to the intestine, as they have been
reported to enter the peripheral circulation and to participate in peripheral tissue metabolism. In the
systemic circulation, they affect energy homeostasis and metabolism by regulating mitochondrial
functions and dynamics in brown adipocytes, liver, and skeletal muscle via G protein-coupled receptor
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(GPR) 41 and 43 [9–13]. Although glucose metabolism has shown to be impacted by acetate and
butyrate, there are no studies yet that address the effects of SCFAs on pancreatic islets [14,15].
Islets are known to express the SCFA receptors GPR 41 and 43, indicating that SCFAs might be
involved in islet-cell metabolism and mitochondrial function [16,17]. Mitochondrial dysfunction of
the insulin-producing β-cells might lead to β-cell apoptosis through the generation of free radicals
and eventually to metabolic disorder and diabetes [18,19]. SCFAs might beneficially impact several
processes in the mitochondria of β-cells. They might affect mitochondrial fusion proteins, e.g., atrophy
(OPA1) and mitofusin (MFN) 1 and 2, and fission proteins, e.g., dynamin-related protein 1 (DRP1) and
fission protein 1 (FIS1) [20]. An increase in fusion proteins might protect cells against toxin-induced
apoptosis, whereas fission is associated with the generation of mitochondrial fragments, which occurs
in the early stages of cell apoptosis [21]. If SCFAs impact these proteins, it might be involved in the
support of mitochondrial function, efficiency, and dynamics during stress, which might contribute to
the prevention of β-cell dysfunction and save β-cells both in type 1 and type 2 diabetes.
To gain insight in a possible role of acetate and butyrate in β-cell function, we investigated the
impact of acetate and butyrate on the viability and mitochondrial function of both human islets and
a mouse β-cell line, as no adequate human β-cell line was available. This was done in the presence and
absence of the well-known apoptosis inducer in β-cells, streptozotocin (STZ). The impact and rescuing
effects of acetate and butyrate on basal respiration, ATP-linked respiration, and spare respiration was
investigated. As STZ induces cell death via the generation of free radicals and nitric oxide (NO),
the impact of acetate and butyrate was also studied on the generation of these molecules during
exposure to STZ. Our data demonstrate that SCFAs enhance the metabolism of β-cells and can protect
cells from many deleterious processes in an SCFA-dependent fashion.
2. Results
2.1. SCFAs Influence Human Islet Cell Viability in a Dose-Dependent Manner
To investigate the potential role of SCFAs in the support of islet viability, we tested the impact
of acetate and butyrate on human cadaveric pancreatic islets. As shown in Figure 1A, acetate had
a beneficial effect on islet viability, as it induced a 20.5 ± 4.4% (p < 0.01) increase at 1 mM compared to
the untreated control cells. However, the higher dose of 4 mM acetate significantly decreased islet
viability by 20.3 ± 3.3% (p < 0.001). Butyrate also had a dose-dependent effect on islet viability; 1 mM
butyrate showed a significant increase of 25.7 ± 3.2% (p < 0.001) compared to untreated controls,
whereas the higher dosage of 4 mM led to a significant decrease in cell viability by 13.2 ± 4.1% (p < 0.05).
Since acetate and butyrate at a concentration of 1 mM positively influenced islet viability,
we performed immunofluorescent staining on human islets to confirm the expression of the two major
receptors for SCFAs GPR41 and 43. As shown in Figure 1B,C, both GPR41 and 43 are expressed in
human islets. The expression of GPR41 was reduced when the islets were incubated with SCFAs.
Acetate at high concentration, i.e., 2 mM and 4 mM, decreased the GRP41 expression, and butyrate
at 1, 2, and 4 mM inhibited expression of this receptor. Neither of the tested SCFAs influenced the
expression of GPR43.
To investigate the impact of the tested SCFAs on insulin synthesis, islets were stained with insulin
antibody after incubation with acetate or butyrate at a concentration of 1, 2, and 4 mM for 24 h.
As shown in Figure 1D, neither of the tested SCFAs influenced the expression of insulin.
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Figure 1. Effects of acetate and butyrate on the viability and expression of G protein-coupled receptor 
41 (GPR41) and GPR43 in human islets. Human islets were incubated with 1, 2, or 4 mM acetate or 
butyrate for 24 h. Cell viability was quantified with water soluble tetrazolium salt 1 (WST-1) assay 
(A), and GPR41 (B), GRP43 (C), and insulin (D) protein were visualized with immunofluorescence. 
Results are plotted as mean ± SEM (n = 5, different donors). Islets incubated with only fluorescent-
conjugated second antibody served as negative control. The statistical differences were quantified 
using one-way ANOVA analysis with Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01, 
*** p < 0.001, compared to the untreated control group). Scale bar denotes 100 µm. 
2.2. SCFAs Influence β-cell Viability 
Islets are clusters of several different cell types. To investigate the involvement of the insulin-
producing β-cells in the SCFAs-induced effect, we determined the effect of our SCFAs on a mouse 
MIN6 β-cell line. Acetate and butyrate also had a dose-dependent effect on β-cell viability (Figure 
2A). Acetate at 1 mM showed a significant increased viability of 22 ± 5.9% (p < 0.05) compared to 
untreated controls, whereas acetate at 4 mM a decrease in viability with 27.6 ± 6.2% (p < 0.01) was 
observed. Butyrate at 1 mM also had a beneficial effect on β-cell viability, as it induced a 29.6 ± 5.0% 
(p < 0.001) increase in cell viability compared with the untreated control. Butyrate at higher 
concentrations, i.e., 2 mM and 4 mM, did not influence viability. 
To further confirm the presence of SCFA receptors on β-cells, PCR and Western blot were 
performed on RNA (Supplementary Figure S1) and protein isolated from MIN6 cells (Figure 2B). 
Neither GPR41 nor GPR43 mRNA changed before or after incubation with the tested SCFAs. 
However, the protein expression of GPR41 was suppressed by 2 and 4 mM acetate, resulting in a 
Figure 1. Effects of acetate and butyrate on the viability and expression of G protein-coupled receptor
41 (GPR41) and GPR43 in human islets. Human islets were incubated with 1, 2, or 4 mM acetate or
butyrate for 24 h. Cell viability was quantified with water soluble tetrazolium salt 1 (WST-1) assay (A),
and GPR41 (B), GRP43 (C), and insulin (D) protein were visualized with immunofluorescence. Results
are plotted as mean ± SEM (n = 5, different donors). Islets incubated with only fluorescent-conjugated
second antibody served as negative control. The statistical differences were quantified using one-way
ANOVA analysis with Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01, *** p < 0.001,
compared to the untreated control group). Scale bar denotes 100 µm.
2.2. SCFAs Influence β-cell Viability
Islets are clusters of several different cell types. To investigate the involvement of the insulin-
producing β-cells in the SCFAs-induced effect, we determined the effect of our SCFAs on a mouse
MIN6 β-cell line. Acetate and butyrate also had a dose-dependent effect on β-cell viability (Figure 2A).
Acetate at 1 mM showed a significant increased viability of 22 ± 5.9% (p < 0.05) compared to untreated
controls, whereas acetate at 4 mM a decrease in viability with 27.6 ± 6.2% (p < 0.01) was observed.
Butyrate at 1 mM also had a beneficial effect on β-cell viability, as it induced a 29.6 ± 5.0% (p < 0.001)
increase in cell viability compared with the untreated control. Butyrate at higher concentrations,
i.e., 2 mM and 4 mM, did not influence viability.
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To further confirm the presence of SCFA receptors on β-cells, PCR and Western blot were
performed on RNA (Supplementary Figure S1) and protein isolated from MIN6 cells (Figure 2B).
Neither GPR41 nor GPR43 mRNA changed before or after incubation with the tested SCFAs. However,
the protein expression of GPR41 was suppressed by 2 and 4 mM acetate, resulting in a significant
decline by 19.2 ± 4.3% (p < 0.05) and 32.0 ± 9.6% (p < 0.01), respectively (Figure 2C). There was no
decline at a concentration of 1 mM butyrate, while at 1, 2, and 4 mM, butyrate significantly suppressed
the expression of GPR41 by respectively 63.8 ± 2.3%, 64.9 ± 6.2% and 59.9 ± 4.0% (p < 0.001). The tested
SCFAs did not influence the protein expression of GPR43 (Figure 2D).
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Figure 2. Effects of acetate and butyrate on mouse insulinoma MIN6 β-cell viability and expression 
of GPR41 and GPR43. MIN6 cells incubated with acetate or butyrate for 24 h. (A) Cell viability was 
determined by WST-1 assay. The expressions of GPR41 and GPR43 were investigated by Western blot 
(B). Western blot results were analyzed by using Image J gradation analysis of GRP41 (C) and GRP43 
(D). Results are represented as mean ± SEM (n = 5). The statistical differences were quantified using 
one-way ANOVA analysis with Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01,  
*** p < 0.001, compared to the untreated control group). 
2.3. SCFAs Prevent Islet Cell-Death During Exposure to STZ 
To investigate the effects of acetate and butyrate on human islets under stress, islet viability was 
also quantified before and after exposure to the β-cell toxin STZ.  
STZ markedly decreased the islet cell viability in human islets by 51.4 ± 6.5% (p < 0.001)  
(Figure 3A). However, pre-incubation with 1 mM acetate prevented STZ-induced cell death with  
45.4 ± 9.9% (p < 0.01). In addition, 1 mM butyrate prevented STZ-induced cell death, as 45.6 ± 9.1%  
(p < 0.01) more cells stayed viable after STZ exposure. Higher concentrations were tested as well, but 
rescuing effects were only observed at 1 mM SCFAs. 
STZ not only decreased islet cell metabolism, it also significantly induced islet-cell apoptosis in 
64.2 ± 5.4% (p < 0.001) (Figure 3B,C) of the cells. This effect was suppressed by both acetate and 
butyrate at 1 mM. Acetate exposure at 1 mM inhibited apoptosis by 53.1 ± 5.5% (p < 0.001) and 
butyrate at the same concentration ameliorated apoptosis with 53.4 ± 5.4% (p < 0.001). At 
concentrations of 2 and 4 mM, acetate could not prevent the STZ-induced apoptosis. Butyrate at  
2 mM effectively ameliorated excessive apoptosis, but at a concentration of 4 mM SCFAs, it could not 
prevent STZ-induced apoptosis. 
Figure 2. Effects of acetate and butyrate on mouse insulinoma MIN6 β-cell viability and expression
of GPR41 and GPR43. MIN6 cells incubated with acetate or butyrate for 24 h. (A) Cell viability was
determined by WST-1 assay. The expressions of GPR41 and GPR43 were investigated by Western
blot (B). Western blot results were analyzed by using Image J gradation analysis of GRP41 (C) and
GRP43 (D). Results are represented as mean ± SEM (n = 5). The statistical differences were quantified
using one-way ANOVA analysis with Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01,
*** p < 0.001, compare to the untreated control group).
2.3. SCFAs Prevent Islet Cell-Death During Exposure to STZ
To investigate the effects of acetate and butyrate on human islets under stress, islet viability was
also quantified before and after exposure to the β-cell toxin STZ.
STZ markedly decreased the islet cell viability in human islets by 51.4 ± 6.5% (p < 0.001)
(Figure 3A). However, pre-incubation with 1 mM acetate prevented STZ-induced cell death with
45.4 ± 9.9% (p < 0.01). In addition, 1 mM butyrate prevented STZ-induced cell death, as 45.6 ± 9.1%
(p < 0.01) more cells stayed viable after STZ exposure. Higher concentrations were tested as well,
but rescuing effects were only observed at 1 mM SCFAs.
STZ not only decreased islet cell metabolism, it also significantly induced islet-cell apoptosis in
64.2± 5.4% (p < 0.001) (Figure 3B,C) of the cells. This effect was suppressed by both acetat nd butyrate
at 1 mM. Acetate exposure at 1 mM inhibited apoptosis by 53.1 ± 5.5% (p < 0.001) and butyrate at the
same concentration ameliorated apoptosis with 53.4 ± 5.4% (p < 0.001). At concentrations of 2 and
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4 mM, acetate could not prevent the STZ-induced apoptosis. Butyrate at 2 mM effectively ameliorated
excessive apoptosis, but at a concentration of 4 mM SCFAs, it could not prevent STZ-induced apoptosis.Int. J. Mol. Sci. 2020, 21, 1542 5 of 17 
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(SCFA) and 5 mM STZ for 24 h. (A) Islet cell viability was determined by WST-1 assay. (B) Islet cell 
apoptosis was detected by Annexin V and propidium iodide (PI) staining. Scale bar denotes 50 µm. 
(C) Islet Annexin PI staining results were analyzed by using Image J gradation analysis. Human islets 
were tested from 5 donors. (D) MIN6-cell viability was determined by WST-1 assay. (E) MIN6 cell 
apoptosis was detected using a flow cytometric assay with Annexin V and PI staining. Results are 
plotted as mean ± SEM (n = 5). The statistical differences were quantified using one-way ANOVA 
analysis with Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01, *** p < 0.001); ns, not 
significant. 
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To determine whether the tested SCFAs influence β-cell survival under stress, cell viability and 
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human islets, STZ markedly decreased MIN6 β-cell viability by 47.0 ± 4.7% (p < 0.001) (Figure 3D). 
However, a pre-incubation with low-dosage SCFAs prevented this decrease. Acetate in a 
concentration of 1 mM prevented STZ-induced cell apoptosis with 32.9 ± 11.3% (p < 0.01). In addition, 
1 mM butyrate prevented apoptosis with 31.5 ± 3.9% (p < 0.001). Higher concentrations were tested, 
but also here, the rescuing effects were only observed at 1 mM SCFAs. 
STZ also induced apoptosis in 32.5 ± 1.3% of the β-cells. This pro-apoptotic effect was 
significantly suppressed by both acetate and butyrate in a dose-dependent manner in STZ-treated 
MIN6 cells (Figure 3E). Acetate exposure at a concentration of 1 and 2 mM markedly prevented 
Figure 3. Effects of acetate and butyrate on viability and apoptosis in streptozotocin (STZ)-treated
human islets nd MIN6-cells. Following pre-incubation with the indicated concentra i n of a etate or
butyrate for 1 h, islets and MIN6-cells were co-incubated with the tested short-chain fatty acids (SCFA)
and 5 mM STZ for 24 h. (A) Islet cell viability was determined by WST-1 assay. (B) Islet cell apoptosis
was detected by Annexin V and propidium iodide (PI) staining. Scale bar denotes 50µm. (C) Islet
Annexin PI staining results were analyzed by using Image J gradation analysis. Human islets were
tested from 5 donors. (D) MIN6-cell viability was etermine by WST-1 assay. (E) MIN6 cell poptosis
was detected using a flow cytometric assay with Annexin V and PI staining. Results are plotted as
mean ± SEM (n = 5). The statistical differences were quantified using one-way ANOVA analysis with
Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01, *** p < 0.001); ns, not significant.
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2.4. SCFAs Promote β-Cell Survival in the Presence of STZ
To determine whether the tested SCFAs influence β-cell survival under stress, cell viability and
apoptosis were also investigated in STZ-exposed MIN6 cells. In concordance with the results with
human islets, STZ markedly decreased MIN6 β-cell viability by 47.0 ± 4.7% (p < 0.001) (Figure 3D).
However, a pre-incubation with low-dosage SCFAs prevented this decrease. Acetate in a concentration
of 1 mM prevented STZ-induced cell apoptosis with 32.9 ± 11.3% (p < 0.01). In addition, 1 mM butyrate
prevented apoptosis with 31.5 ± 3.9% (p < 0.001). Higher concentrations were tested, but also here,
the rescuing effects were only observed at 1 mM SCFAs.
STZ also induced apoptosis in 32.5 ± 1.3% of the β-cells. This pro-apoptotic effect was significantly
suppressed by both acetate and butyrate in a dose-dependent manner in STZ-treated MIN6 cells
(Figure 3E). Acetate exposure at a concentration of 1 and 2 mM markedly prevented apoptosis with
20.6 ± 1.7% (p < 0.001) and 5.8 ± 2.3% (p < 0.05). At 4 mM, acetate could not prevent the STZ-induced
apoptosis increase. Butyrate at 1 and 2 mM significantly prevented apoptosis with 21.8 ± 2.0%
(p < 0.001) and 7.7 ± 1.7% (p < 0.01). In addition, butyrate at a concentration of 4 mM could not
ameliorate the apoptosis induced by STZ.
2.5. SCFAs Support β-cell Mitochondrial Respiration and Protect Against STZ-induced β-cell OCR Reduction
To determine how acetate and butyrate beneficially impact cell metabolism, we determined
the oxygen consumption rate (OCR), which is an indicator of mitochondrial respiration in β-cells
(Figure 4A) [22]. We used OCR and not glucose-induced insulin secretion, as it has been reported
that OCR correlates better and allows for the quantification of smaller differences in viability and
function [23]. It was only done at 1 mM SCFAs, as we found beneficial effects at this concentration.
As these assays require a high amounts of cells, it could only be performed with MIN6 cells and
not with the rarely available human islets. As shown in Figure 4B–E, acetate induced a statistically
significant beneficial effect on β-cell OCR and stimulated all mitochondrial respiration processes.
Acetate enhanced basal respiration by 22.2 ± 7.6% (p < 0.05) (Figure 4C), ATP-linked respiration by
23.7 ± 7.7% (p < 0.05) (Figure 4D), and spare respiration by 24.4 ± 6.2% (p < 0.01) (Figure 4E). Butyrate
did not boost β-cell mitochondrial respiration compared to the control group.
To investigate whether the tested SCFAs also protect β-cell respiration under STZ-induced stress,
MIN6 cell OCR was quantified before and after exposure to STZ with and without exposure to SCFA.
STZ has a strong negative impact on OCR (Figure 4B), and it was differentially prevented by acetate
and butyrate in β-cells. MIN6 cells incubated with STZ showed a decreased respiration rate, including
a significantly decreased basal respiration by 44.0 ± 5.3% (p < 0.001), reduced ATP production by
63.0 ± 7.8% (p < 0.001), and spare respiration by 58.3 ± 4.7% (p < 0.001) (Figure 4B–E). Acetate
almost completely prevented these negative effects of STZ. Mitochondrial basal respiration rate, spare
respiration, and ATP-linked respiration reduction stayed identical to the untreated controls when cells
were exposed to acetate and STZ. Butyrate had a partial rescuing effect. Cells exposed to butyrate
before STZ treatment had a 37.7 ± 2.4% (p < 0.01) higher basal respiration, 53.8 ± 5.6% (p < 0.01) higher
ATP-linked respiration, and 46.5 ± 3.5% (p < 0.001) higher spare respiration than cells exposed to STZ
without butyrate.
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Figure 4. Effects of acetate and butyrate on oxygen consumption rate (OCR) of MIN6-cells. (A) A 
schematic overview of the mitochondrial stress test. Arrows indicate the subsequent addition of the 
ATPase inhibitor oligomycin, the uncoupling reagent phenyl hydrazone (FCCP), and the inhibitors 
of the electron transport chain rotenone/antimycin A. (B) MIN6 cell were seeded in a Seahorse cell 
culture plate; after incubation with 1 mM of acetate or butyrate, STZ at a final concentration of 5 mM 
was added to each well and incubated for 24 h. The OCR of each treated cell was investigated using 
a Seahorse Biosience XF24 extracellular flux analyzer. Figures C–E respectively represent individual 
parameters for basal respiration (C), ATP-linked respiration (D), and spare respiration (E). Results 
are plotted as mean ± SEM (n = 5). The statistical differences were quantified using one-way ANOVA 
analysis with Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01, *** p < 0.001). 
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for functional mitochondria after cell damage [12]. Islets (Figure 5A) or MIN6 cells (Figure 5B) were 
first incubated with acetate or butyrate in the absence of STZ to investigate the influence of the tested 
SCFAs on healthy insulin-producing β cells. Under normal culture conditions, acetate and butyrate 
did not affect the expression of mitochondrial dynamic genes.  
However, this was different following STZ exposure. After incubation with STZ, the fusion 
genes MFN1, MFN2, and OPA1 were found to be statistically significantly downregulated in human 
islets by respectively 65.3 ± 14.0% (p < 0.01), 75.5 ± 12.5% (p < 0.001), and 57.1 ± 11.8% (p < 0.01)  
(Figure 5C). Furthermore, the expression of the fission genes DRP1 and FIS1 was statistically 
significantly increased in STZ-treated human islets by respectively 68.4 ± 15.5% (p < 0.01) and  
66.0 ± 12.4% (p < 0.001). This indicates that STZ induces a reduction in fusion and a stimulation of 
fission in human islets. Under STZ-induced mitochondrial stress, acetate prevented against the  
STZ-induced reduction of the fusion genes MFN1 (p < 0.001) and MFN2 (p < 0.001), which were 
Figure 4. Effects of acetate and butyrate on oxygen consumption rate (OCR) of MIN6-cells.
(A) A schematic overview of the mitochondrial stress test. Arrows indicate the subsequent addition of
the ATPase inhibitor oligomycin, the uncoupling reagent phenyl hydrazone (FCCP), and the inhibitors
of the electron transport chain rotenone/antimycin A. (B) MIN6 cell were seeded in a Seahorse cell
culture plate; after incubation with 1 mM of acetate or butyrate, STZ at a final concentration of 5 mM
was added to each well and incubated for 24 h. The OCR of each treated cell was investigated using
a Seahorse Biosience XF24 extracellular flux analyzer. Figures C–E respectively represent individual
parameters for basal respiration (C), ATP-linked respiration (D), and spare respiration (E). Results are
plotted as mean ± SEM (n = 5). The statistical differences were quantified using one-way ANOVA
analysis with Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01, *** p < 0.001).
2.6. SCFAs Affect β-cells Mitochondrial Dynamics under STZ-Induced Stress
In order to gain insight into the possible mechanisms involved in the rescuing effects of acetate
and butyrate on mitochondrial respiratory functions after the STZ exposure of β-cells, we studied the
effect of acetate and butyrate on mitochondrial fission and fusion, as these are important processes
for functional mitochondria after cell damage [12]. Islets (Figure 5A) or MIN6 cells (Figure 5B) were
first incubated with acetate or butyrate in the absence of STZ to investigate the influence of the tested
SCFAs on healthy insulin-producing β cells. Under normal culture conditions, acetate and butyrate
did not affect the expression of mitochondrial dynamic genes.
Int. J. Mol. Sci. 2020, 21, 1542 8 of 17
Int. J. Mol. Sci. 2020, 21, 1542 8 of 17 
 
comparable with the untreated control groups. The reduction of OPA1 was prevented by 45.3 ± 12.9% 
(p < 0.05). Additionally, acetate prevented the increase in the fission genes DRP1 with 65.3 ± 5.9%  
(p < 0.01) and FIS1 with 55.5 ± 7.1% (p < 0.05). In addition, butyrate showed similar pro-fusion and 
anti-fission effects. Butyrate almost completely prevented the STZ-induced decrease in the fusion 
genes MFN1 (p < 0.01) and MFN2 (p < 0.001) compared to islets exposed to only STZ. The decrease of 
another mitochondrial fusion gene OPA1 was prevented by 47.1 ± 17.6% (p < 0.05) compared to islets 
with only STZ-exposure. In addition, butyrate moderated the upregulation of fission gene DRP1  
(p < 0.01) to control level and FIS1 by 47.1 ± 17.6% (p < 0.01). 
We repeated the experiments with MIN6 β-cells. In addition, here, the presence of STZ showed 
a pro-fission and anti-fusion effect. The fusion genes MFN1, MFN2, and OPA1 were found to be 
statistical significantly downregulated in β-cells by respectively 23.4 ± 2.7% (p < 0.01), 36.2 ± 5.4%  
(p < 0.001), and 56.9 ± 2.3% (p < 0.001) (Figure 5D). The expression of the fission genes DRP1 and FIS1 
were upregulated by 48.1 ± 4.3% (p < 0.001) and 43.9 ± 4.0% (p < 0.001). Both acetate and butyrate 
showed pro-fusion and anti-fission effects in STZ-treated MIN6 cells, which prevented the decrease 
in the fusion genes MFN1 (p < 0.001), MFN2 (p < 0.001), and OPA1 (p < 0.001); it also prevented the 
increase in the fission genes DRP1 (p < 0.001) and FIS1 (p < 0.001) compared to cells with only  
STZ-exposure. 
 
Figure 5. Effect of acetate and butyrate on mitochondrial fusion and fission gene expression in human 
islets and MIN6-cells. Islets (A,C) and MIN6-cells (B,D) were incubated with 1 mM acetate or butyrate 
in the absence (A,B) or presence (C,D) of 5 mM STZ for 24 h. The expression level of the mitochondrial 
fusion and fission genes were quantified with qPCR analysis. Results are plotted as mean ± SEM  
(n = 5). The statistical differences were quantified using one-way ANOVA analysis with  
Newman–Keuls multiple comparisons test (* p < 0.5, ** p < 0.01, *** p < 0.001). 
2.7. SCFAs Attenuate STZ-induced Generation of Free Radicals  
As ROS and NO release are hallmarks of STZ-induced islet toxicity, we also studied whether 
acetate and butyrate impact ROS and NO release in islets [24]. In human islets, STZ increased the 
production of ROS by 59.3 ± 3.6% (p < 0.001) (Figure 6A). This increase was prevented by acetate  
(p < 0.001) as well as by butyrate (p < 0.001). Notably, acetate showed a significantly more effective 
anti-ROS (reactive oxygen species) effect in human islets (p < 0.05). STZ had a strong impact on NO 
Figure 5. Effect of acetate and butyrate on mitochondrial fusion and fission gene expression in human
islets and MIN6-cells. Islets (A,C) and MIN6-cells (B,D) were incubated with 1 mM acetate or butyrate
in the absence (A,B) or pre ence (C,D) of 5 mM STZ for 24 h. The expression level of the mitochondrial
fusion and fission genes were quantified with qPCR analysis. Results are plotted as mean ± SEM
(n = 5). The statistical differences were quantified using one-way ANOVA analysis with Newman–Keuls
multiple comparisons test (* p < 0.5, ** p < 0.01, *** p < 0.001).
However, this was different following STZ exposure. After incubation with STZ, the fusion genes
MFN1, MFN2, and OPA1 were found to be statistically significantly downregulated in human islets by
respectively 65.3 ± 14.0% (p < 0.01), 75.5 ± 12.5% (p < 0.001), and 57.1 ± 11.8% (p < 0.01) (Figure 5C).
Furthermore, the expression of the fission gen s DRP1 and FIS1 was statist cally significantly incr ased
in STZ-treated human islets by res ectively 68.4 ± 15.5% (p < 0.01) and 66.0 ± 12.4% (p < 0.001).
This indicates that STZ induces a reduction in fusion and a stimul tion of fission in human islets.
Under STZ-induced mitochondrial stress, acetate prevented against the STZ-induced reduction of
the fusion genes MFN1 (p < 0.001) and MFN2 (p < 0.001), which were comparable with the untreated
control groups. The reduction of OPA1 was prevented by 45.3 ± 12.9% (p < 0.05). Additionally,
acetate prevented the increase in the fission genes DRP1 with 65.3 ± 5.9% (p < 0.01) and FIS1 with
55.5 ± 7.1% (p < 0.05). In addition, butyrate showed similar pro-fusion and anti-fission effects. Butyrate
almost completely prevented the STZ-induced decrease in the fusion genes MFN1 (p < 0.01) and MFN2
(p < 0.001) compared to islets exposed to only STZ. The decrease of another mitochondrial fusion gene
OPA1 was prevented by 47.1 ± 17.6% (p < 0.05) compared to islets with only STZ-exposure. In addition,
butyrate moderated the upregulation of fission gene DRP1 (p < 0.01) to control level and FIS1 by
47.1 ± 17.6% (p < 0.01).
We repeated the experiments with MIN6 β-cells. In addition, here, the presence of STZ showed
a pro-fission and anti-fusion effect. The fusion genes MFN1, MFN2, and OPA1 were found to be
statistical significantly downregulated in β-cells by respectively 23.4 ± 2.7% (p < 0.01), 36.2 ± 5.4%
(p < 0.001), and 56.9 ± 2.3% (p < 0.001) (Figure 5D). The expression of the fission genes DRP1 and FIS1
were upregulated by 48.1 ± 4.3% (p < 0.001) and 43.9 ± 4.0% (p < 0.001). Both acetate and butyrate
showed pro-fusion and anti-fission effects in STZ-treated MIN6 cells, which prevented the decrease in
the fusion genes MFN1 (p < 0.001), MFN2 (p < 0.001), and OPA1 (p < 0.001); it also prevented the increase
in the fission genes DRP1 (p < 0.001) and FIS1 (p < 0.001) compared to cells with only STZ-exposure.
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2.7. SCFAs Attenuate STZ-induced Generation of Free Radicals
As ROS and NO release are hallmarks of STZ-induced islet toxicity, we also studied whether acetate
and butyrate impact ROS and NO release in islets [24]. In human islets, STZ increased the production
of ROS by 59.3 ± 3.6% (p < 0.001) (Figure 6A). This increase was prevented by acetate (p < 0.001) as well
as by butyrate (p < 0.001). Notably, acetate showed a significantly more effective anti-ROS (reactive
oxygen species) effect in human islets (p < 0.05). STZ had a strong impact on NO synthesis in human
islets, which was enhanced by 68.6 ± 4.2% (p < 0.001) (Figure 6B). Acetate prevented nearly half of
this STZ-induced NO production (p < 0.001). Butyrate more effectively inhibited the STZ-induced NO
production (p < 0.001), whose efficiency was 39.0 ± 5.1% (p < 0.001) higher than that of acetate (Figure 6B).
We also studied ROS and NO generation induced by STZ in a MIN6 cell line. As shown in Figure 6C,
after incubation with STZ, ROS generation was statistically significantly increased with 55.1 ± 4.7%
(p < 0.001) in the STZ-treated MIN6 cells. Acetate inhibited this STZ-induced increase (p < 0.001), as well
as butyrate (p < 0.001). STZ enhanced NO in MIN6 cells with 36.8 ± 3.5% (p < 0.001) (Figure 6D).
Acetate prevented this STZ-induced increase (p < 0.001) as well as butyrate (p < 0.001). In the MIN6 cell line,
there was no significant difference in the ability of acetate and butyrate to reduce free radical generation.
Our findings suggest that the tested SCFAs inhibit STZ-induced oxidative and nitrosative stress in islet
β-cells by reducing ROS and NO levels, but the efficiency in human islets is SCFA-dependent.
Int. J. Mol. Sci. 2020, 21, 1542 9 of 17 
 
synthesis in human islets, which was enhanced by 68.6 ± 4.2% (p < 0.001) (Figure 6B). Acetate 
prevented nearly half of this STZ-induced NO production (p < 0.001). Butyrate more effectively 
inhibited the STZ-induced NO production (p < 0.001), whose efficiency was 39.0 ± 5.1% (p < 0.001) 
higher than that of acetate (Figure 6B).  
We also studied ROS and NO generation induced by STZ in a MIN6 cell line. As shown in Figure 
6C, after incubation with STZ, ROS generation was statistically significantly increased with  
55.1 ± 4.7% (p < 0.001) in the STZ-treated MIN6 cells. Acetate inhibited this STZ-induced increase  
(p < 0.001), as well as butyrate (p < 0.001). STZ enhanced NO in MIN6 cells with 36.8 ± 3.5% (p < 0.001) 
(Figure 6D). Acetate prevented this STZ-induced increase (p < 0.001) as well as butyrate (p < 0.001). 
In the MIN6 cell line, there was no significant difference in the ability of acetate and butyrate to reduce 
free radical generation. Our findings suggest that the tested SCFAs inhibit STZ-induced oxidative 
and nitrosative stress in islet β-cells by reducing ROS and NO levels, but the efficiency in human 
islets is SCFA-dependent. 
 
Figure 6. Effects of acetate and butyrate on STZ-induced free radical generation in human islets and 
MIN6-cells. Human islets (A,B) and MIN6-cells (C,D) were incubated with 1 mM acetate or butyrate 
for 1 h followed by 24 h incubation with 5 mM STZ. Intracellular reactive oxygen species (ROS) was 
measured with a 2′,7′-dichlorofluorescin diacetate (DCFDA) Cellular ROS Detection Assay Kit (A,C). 
The fluorescence signal was monitored at Ex/Em = 485/535 nm. Nitric oxide (NO) was detected using 
a Nitric Oxide Assay Kit (B,D). Results represent mean ± SEM (n = 5). The statistical differences were 
quantified using one-way ANOVA analysis with Newman–Keuls multiple comparisons test (* p < 0.5, 
*** p < 0.001). 
3. Discussion 
Pancreatic β-cells are very sensitive to oxidative stress-induced mitochondrial dysfunction due 
to a relatively weak enzymatic anti-oxidative defense mechanism along with an inefficient repair 
system for oxidative DNA damage [25,26]. This is a major cause of islet loss in the process toward 
both type 1 and type 2 diabetes. Many report the beneficial effects of SCFA on glucose metabolism 
[14,15], but most of these effects are attributed to the increasing insulin sensitivity of peripheral 
Figure 6. Effects of acetate and butyrate on STZ-induced free radical generation in human islets and
MIN6-cells. Human islets (A,B) and MIN6-cells (C,D) were incubated with 1 mM acetate or butyrate
for 1 h followed by 24 h incubation with 5 mM STZ. Intracellular reactive oxygen species (ROS) was
measured with a 2′,7′-dichlorofluorescin diacetate (DCFDA) Cellular ROS Detection Assay Kit (A,C).
The fluorescence signal was monitored at Ex/Em = 485/535 nm. Nitric oxide (NO) was detected using
a Nitric Oxide As ay Kit (B,D). Results represent mean ± SEM (n = 5). The statistical differences were
quantified using one-way ANOVA analysis with Newman–Keuls multipl comparisons test (* p < 0.5,
*** p < 0.001).
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3. Discussion
Pancreatic β-cells are very sensitive to oxidative stress-induced mitochondrial dysfunction due
to a relatively weak enzymatic anti-oxidative defense mechanism along with an inefficient repair
system for oxidative DNA damage [25,26]. This is a major cause of islet loss in the process toward both
type 1 and type 2 diabetes. Many report the beneficial effects of SCFA on glucose metabolism [14,15],
but most of these effects are attributed to the increasing insulin sensitivity of peripheral organs rather
than directly impacting β-cells to keep producing insulin under stress. Previous studies have shown
that SCFAs may stimulate the antioxidant defense against e.g., ischemia–reperfusion injury in cell
types other than β-cells such as in brain cells [27]. In addition, SCFAs have been shown to support
mitochondrial function in mouse liver, skeletal muscle, and fat cells [12,13,28]. This was the main
rational to test the impact of SCFAs on β-cells [29,30]. In addition, we tested how SCFAs can reduce
oxidative and nitrosative stress in human islets and β-cells after exposure to STZ [31]. We demonstrate
the strong viability promoting effects and protection against oxidative and nitrosative stress by both
acetate and butyrate at lower concentrations of 1 mM, while higher concentrations had adverse effects.
Both human islets and a β-cell line were studied. Despite amble experience with isolating β-cells
from human islets [32], we were unable to collect sufficient cells for reliably performing OCR on the
cells. The applied OCR technique requires too many islets. Therefore, we choose the strategy to use
MIN6 cells for the assays where high numbers of islets are needed. Here, with the usage of both
human islets and the MIN6 mouse β-cell line, we proved the direct effect of SCFAs on islets and β-cells.
In human islets, we show that acetate and butyrate at 1 mM supported cell metabolism and prevented
cell death. In the presence of STZ, the impact of both SCFAs was even more pronounced. Several
studies have demonstrated that STZ induces damage mainly by provoking ROS and NO production in
islet cells [33,34]. Therefore, as a possible mechanism for the protective effects of SCFAs, we measured
after exposure to SCFAs the ROS/NO levels, mitochondrial function, and expression of GPR receptors.
Incubation with 1 mM of both SCFAs strongly attenuated STZ-induced overproduction of ROS and
NO, which might be caused by multiple mechanisms, including the amelioration of mitochondrial
damage by supporting mitochondrial metabolism as an energy source. These two SCFAs seem to
be able to reduce this oxidative stress, leading to improved islet-cell survival via, as we show here,
regulating essential genes involved in mitochondrial dynamics. We observed a shift toward the fusion
genes (MFN1, MFN2, and OPA1) and a downregulation of the mitochondrial fission genes (DRP1 and
FIS1) [12,35]. The shift toward mitochondrial fusion is known to improve not only mitochondrial cell
energy metabolism but also to reduce radical overproduction [36,37].
The SCFAs effects were dose-dependent; acetate and butyrate at a concentration of 1 mM enhanced
β-cell viability and showed slightly improved metabolism at 2 mM, but no protective effects were
observed at 4 mM. The physiological concentrations of acetate and butyrate in the portal and peripheral
circulation were also found to be approximately 1 mM [38,39]. The loss of protection at higher
concentrations and observed enhanced apoptosis at 4 mM with both SCFAs might be caused by
multiple mechanisms. A plausible explanation is a lowering of intracellular pH induced by excessive
SCFAs entering β-cells via free diffusion. Other explanations are that the oxidative and mitochondrial
stress caused by an incomplete fatty acid oxidation increases ketone bodies in the cell and causes cell
death [40,41]. Moreover, a higher concentration of SCFAs may upregulate the transcription of cellular
growth inhibitory genes by modifying their histone acetylation status, leading to cytotoxicity [42,43].
Acetate had a different effect than butyrate. Acetate showed more efficacy in supporting energy
metabolism and anti-oxidative effects than butyrate. This might be caused by adaptations of β-cells to
lower concentrations of butyrate in the pancreatic circulation. Butyrate is present at relatively lower
concentrations compared to acetate because of the preferential use of butyrate by colonic epithelial
cells for energy production [44]. Although there are no studies accurately quantifying and reporting
the physiological concentration of acetate and butyrate surrounding islets, it is likely that butyrate
concentrations will be lower and that β-cells will already benefit from butyrate at a lower concentration
than that of acetate. However, we noticed that butyrate showed stronger effects on inhibiting GPR41
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and NO generation, which suggests that butyrate function in β-cells might rely on a signal-mediated
process via the SCFA receptor GPR41. Butyrate is sensed by GPR41 and stimulates a cascade of the
signal transduction pathway [45,46], resulting in faster and more efficient energy metabolism toward
β-oxidation, and the suppressed synthesis of inducible nitric oxide synthase.
Recently, acetate and propionate have been reported to improve insulin secretion and to protect
against apoptosis in β-cells damaged by the cytokines interferon gamma, tumor necrosis factor alpha,
and interleukin 1 beta and the fatty acid sodium palmitate [16,29]. Pingitore et al. demonstrate that
acetate and propionate stimulate insulin secretion via the phospholipase C/protein kinase C pathways
and that effects are dependent on GPR43. The anti-apoptotic impact of acetate and propionate are
also reported to be GPR43-dependent [16]. Here, we investigate the effect of acetate but also of
another important SCFA butyrate in rescuing β-cells compromised by an insulin-producing β-cell
specific toxin, STZ, that disturbs mitochondrial metabolism [24]. We demonstrate that both acetate and
butyrate rescue STZ-impaired β-cells mitochondrial respiration and promote mitochondrial repair
by inducing a shift toward the fusion process in mitochondria. This is, to the best of our knowledge,
a new mechanism by which SCFAs contribute to rescue of damaged β-cells. Butyrate is an important
SCFA and was not studied by Pingitore et al., but it was shown in our study to contribute together with
acetate to rescue β-cell mitochondrial processes such as respiration, ATP generation, and dynamics
when exposed to STZ. This underlines and corroborates previous studies [16,29], demonstrating that
SCFAs, which are microbial fermentation products of dietary fibers, can play a role in the prevention,
delaying, or treatment of diabetes by making β-cells more resistant to oxidative stress. This is, to the
best of our knowledge, a new mechanism by which dietary fiber intake can contribute to lowering
of the long list of Western diseases. The lower intake of dietary fiber by consumers in Western
countries compared to more traditional societies has been suggested to be one of the major causes of
the increasing occurrence of both type 1 and 2 diabetes [47]. Previous studies explained the effects of
dietary fiber intake and the lowering of diabetes in consumers as an attenuating effect on inflammatory
cells, inhibition of absorption of glucose and fat in the intestine, and increased insulin sensitivity [48,49].
Our study demonstrates and suggests that SCFAs formed from dietary fibers also play an essential role
in supporting β-cell metabolism and promoting survival under stressful conditions.
In conclusion, this study provides new insights into how SCFAs can contribute to the maintenance
of health. It shows that acetate and butyrate support β-cell metabolism, modulate mitochondrial
efficiency and dynamics, and by that provide islet cells with enhanced anti-oxidative responses
by which less ROS and NO is generated when exposed to the β-cell specific toxin STZ. Therefore,
they support pancreatic β-cells function and prevent STZ-induced cell apoptosis.
4. Materials and Methods
4.1. Cell Culture
The MIN6 cell line was purchased from American Type Culture Collection (ATCC, Manassas,
VA, USA). MIN6 cells (passages 30–45) were cultured in (Dulbecco’s Modified Eagle Medium) DMEM
High-glucose medium (Lonza, Basal, Switzerland), containing 15% fetal bovine serum (FBS, Lonza),
50 µmol/L β-mercaptoethanol, 2 mmol/L l-glutamine, 50 U/mL penicillin, and 50 µg/mL streptomycin
(all from Sigma-Aldrich, St. Louis, MO, USA). Cells were cultured at 37 ◦C in a humidified atmosphere
containing 95% air and 5% CO2.
4.2. Human Islet Isolation
Human islets of Langerhans were isolated from cadaveric pancreata at the Leiden University
Medical Center, as previously described [50] and provided through the JDRF award 31-2008-416
(European Consortium for Islet Transplantation, Islet for Basic Research program, Milan, Italy).
The detailed information of islet and donor data are mentioned in supplementary Table S1. Islets
were used for research when the quality and/or number were insufficient for clinical application
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according to national laws and when research consent was available. All the procedures were
approved and carried out in accordance with the code of proper secondary use of human tissue in
The Netherlands as formulated by the Dutch Federation of Medical Scientific Societies. After shipment
to the University Medical Center Groningen, islets were cultured in CMRL-1066 (GIBCO, Bleiswijk,
the Netherlands), supplemented with 10% FBS, 50 U/mL penicillin, and 50 µg/mL streptomycin, as
previously described [51].
4.3. Cell Viability
The effect of SCFAs on β-cell viability was determined by the cell proliferation reagent WST-1
(Roche, Indianapolis, IN, USA). Briefly, human islets (15 islets/well) and MIN6 cells (1 × 104 cells/well)
were seeded in 96-well plates. Islets and cells were cultured overnight and the following day
incubated with or without the acetate (Sigma-Aldrich) or butyrate (Sigma-Aldrich) at 1, 2, and 4 mM
for 24 h followed by WST-1 assay. In order to investigate the protective effect of tested SCFAs,
a one-hour preincubation of SCFA was followed by a 24-h co-incubation of the SCFAs and 5 mM
STZ (Sigma-Aldrich), since STZ is widely reported as causing β-cell destruction and reduced insulin
secretion [52]. Cells without SCFAs and STZ incubation were used as negative control, and cells with
only STZ incubation were used as positive control. After 30 min incubation with WST-1 (10 µL/well)
at 37 ◦C, the absorbance was measured at 450 nm using a Bio-Rad Benchmark Plus microplate
spectrophotometer reader (Bio-Rad Laboratories B.V, Veenendaal, The Netherlands).
4.4. Cell Apoptosis
The effect of acetate and butyrate on β-cell apoptosis was analyzed using an Annexin V (Biolegend,
San Diego, CA, USA) and PI (PI, Thermo Scientific, Eugene, OR, USA) staining. Briefly, human
islets were seeded on gelatin-coated coverslips with a diameter of 10.2 mm (15 islets/slide). MIN6
cells (1 × 106 cells/well) were cultured in 6-well plates. Islets and MIN6 cells were incubated with
or without acetate or butyrate at 1, 2, and 4 mM for 24 h followed by Annexin V/propidium iodide
(PI) staining. In order to investigate the rescue effects of SCFAs, one-hour pre-incubation of tested
SCFA was followed by a 24-h co-incubation of the SCFAs and 5 mM STZ. Cells without tested SCFAs
and STZ incubation were used as negative control. Cells with only STZ incubation were used as
positive control. After incubation, islets and MIN6 cells were incubated for 15 min with 4.5 µg/mL
Alexa Fluor® 488 Annexin V and 1 µg/mL propidium iodide. The staining of human islets was
analyzed using a Leica DM4000 B microscope (Leica Microsystems, Wetzlar, Germany). The percentage
of Annexin V positive area and islet size were measured using ImageJ software (v. 1.47; National
Institutes of Health, Bethesda, MD, USA). MIN6 cells were analyzed by flow cytometry (BD Biosciences,
Breda, The Netherlands). The flow cytometric results were analyzed using FlowJo® 10.4.2 software
(LLC, Ashland, USA), and the number of apoptotic cells was expressed as the percentage of the total
number of cells.
4.5. Mitochondrial Function
The effect of acetate and butyrate on mitochondrial function was measured by seeding MIN6 cells
in XFe24 cell culture microplates (Seahorse Bioscience, North Billerica, MA, USA) at 4 × 104 cells/well.
Cells were cultured as described above. Cells with STZ incubation were used as positive controls,
and cells without SCFAs and STZ incubation were used as negative controls. The cells were washed
with extracellular flux (XF) basic medium (Seahorse Bioscience) supplemented with 3 mM glucose,
2 mM glutamine, and 2 mM sodium pyruvate followed by an incubation in this medium for 60 min
at 37 ◦C in a non-CO2 incubator. Plates were transferred to a Seahorse Bioscience XFe24 extracellular
flux analyzer (Seahorse Bioscience) and subjected to an equilibration period. After measuring the
basal oxygen consumption rate (OCR) for three cycles, oligomycin (1 µM, Sigma-Aldrich) was added
to determine the proportion of respiration used to generate ATP. Then, carbonyl cyanide-4-(trifluoro
methoxy) phenyl hydrazone (FCCP, 1 µM, Sigma-Aldrich) was added to determine the maximal
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respiration by mitochondria. After that, rotenone (0.5 µM, Sigma-Aldrich) and antimycin A (0.5 µM,
Sigma-Aldrich) were added to measure the non-mitochondrial respiratory rate.
4.6. Reactive Oxygen Species (ROS) Assay
Intracellular ROS was detected using a DCFDA Cellular ROS Detection Assay Kit (Abcam,
Cambridge, UK) according to the instructions of the kit manufacturer. Briefly, MIN6 cells (1 × 104/well)
and human islets (10 islets/well) were seeded in black 96-well immunoplates (Thermo Scientific).
Both were cultured and incubated with the tested SCFAs and STZ as described above. They were
incubated with 20 µM 2′,7′-dichlorofluorescin diacetate (DCFDA) at 37 ◦C for 30 min, and fluorescence
was measured (excitation 485 nm, emission 535 nm) using a fluorescence plate reader (PerkinElmer,
Waltham, MA, USA).
4.7. Nitric Oxide
The NO concentration in the supernatant of the MIN6 cells and the human islets was measured
with a Nitric Oxide Assay Kit (Invitrogen, Vienna, Austria) according to the manufacturer’s instructions.
MIN6 cells and human islets were cultured and incubated with the tested SCFAs and STZ as described
above. Briefly, nitrate in the supernatants was converted to nitrite using nitrate reductase. Subsequently,
using Griess reagents, the nitrite was converted to a deep purple azo compound. Then, a Bio-Rad
Benchmark Plus microplate spectrophotometer reader at 540 nm was used to measure the level of azo
compounds, which reflected the NO amount in the sample.
4.8. Immunofluorescence
Immunofluorescent staining was performed to stain for the SCFA receptors GPR41 and GRP43
and insulin. Human islets were cultured and incubated with the tested SCFAs and STZ as described
above. After that, islets were fixed for 15 min with 4% paraformaldehyde (Merck, Darmstadt,
Germany), and non-specific binding was blocked by incubating with 1% bovine serum albumin
(Sigma-Aldrich) for 1 h. The cells and islets were incubated for 1 h at room temperature with the
primary antibodies rabbit anti-GPR41 (Thermo Scientific, 1:100), rabbit anti-GRP43 (Merck, 1:100),
and guinea pig anti-insulin (Dako, Santa Clara, CA, USA, 1:200). After washing, the cells and islets
were incubated for 1 h at room temperature with donkey-anti-rabbit Alexa Fluor® 488 (Thermo
Scientific, 1:500) or goat-anti-guinea pig Alexa Fluor® 488 (Thermo Scientific, 1:500) followed by
a 1-min incubation with (4′,6-Diamidino-2-Phenylindole) DAPI (1.0 µg/mL; Roche). The staining
of GPR41 and 43 was analyzed using a Leica DM4000 B microscope through the hanging drop
method [53]. To this end, islets were placed on a cover slip in a 10 µL phosphate-buffered saline (PBS)
micro-spheroid and subsequently placed upside down, allowing scanning of the islets throughout
the islets. Insulin staining was analyzed using a Leica SP8 confocal microscope. Data were processed
using ImageJ Software.
4.9. Western Blot
Western blot was performed to analyze the protein expression of the SCFA receptors
GPR41 and GPR43. MIN6 cells were cultured as described above and were lysed afterwards
using radioimmunoprecipitation assay buffer (10×, Merck) supplemented with protease inhibitor
(Roche). The protein concentration was determined using the BCA™ Protein Assay Kit (Thermo
Scientific). Proteins were separated by loading a 10% polyacrylamide gel with 20 µg protein per
well. The electrophoresis-separated proteins were subsequently transferred to Immobilon®-FL
polyvinylidene fluoride membranes (Merck) and blocked with Odyssey® blocking buffer (LI-COR,
Leusden, The Netherlands) for 1 h at room temperature. Then, membranes were incubated with the
primary antibody rabbit anti-GPR41 (Thermo Scientific, 1:1000) and rabbit anti-GPR43 (Merck, 1:1000)
in 1× PBS with 0.1% Tween. The mouse anti-β actin antibody (1:500, Santa Cruz, Heidelberg, Germany)
was used as a housekeeping protein. After 4 ◦C incubation overnight, membranes were washed in
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Tris-buffered saline (pH 7.4) and incubated for 1 h at room temperature with secondary antibody IRDye
800CW or 680 CW (LI-COR, 1:20000) in the dark. Membranes were analyzed using a LI-COR Odyssey
Scanner (LI-COR).
4.10. Quantitative Polymerase Chain Reaction (qPCR)
A qPCR was performed to determine the gene expression of mitochondrial fission and fusion
in human islets and MIN6 cells after acetate/butyrate and STZ incubation as described above.
After stimulation, islets and MIN6 cells were homogenized with TRIzol (Life Technologies, Carlsbad,
CA, USA). The total RNA was isolated following the manufacturer’s instructions, followed by
obtaining reverse-transcribed cDNA using SuperScript II Reverse Transcriptase (Invitrogen). qPCR
was performed with a FastStart Universal SYBR-Green Master kit (Roche) for the genes MFN1, MFN2,
DRP1, OPA1, and FIS1 (primer sequences are listed in Table 1). Reactions were carried out in 384-well
PCR plates (Thermo Scientific) using a ViiA7 Real-Time PCR System (Applied Biosystems, Carlsbad,
CA, USA). Delta Ct values were calculated and normalized to the housekeeping gene β-actin. Delta
Delta Ct values were used for the comparative quantification of expression of the genes.
Table 1. Primer sequences for qRT-PCR.
Gene Species Forward Sequence 5′-3′ Reverse Sequence 5′-3′
MFN1 Mouse TCTCCAAGCCCAACATCTTCA ACTCCGGCTCCGAAGCA
MFN2 Mouse ACAGCCTCAGCCGACAGCAT TGCCGAAGGAGCAGACCTT
DRP1 Mouse GCGCTGATCCCGCGTCAT CCGCACCCACTGTGTTGA
OPA1 Mouse TGGGCTGCAGAGGATGGT CCTGATGTCACGGTGTTGATG
FIS1 Mouse GCCCCTGCTACTGGACCAT CCCTGAAAGCCTCACACTAAGG
β-Actin Mouse ACGGCCAGGTCATCACTATTC AGGAAGGCTGGAAAAGAGCC
MFN1 Human TGGCTAAGAAGGCGATTACTGC TCTCCGAGATAGCACCTCACC
MFN2 Human CTCTCGATGCAACTCTATCGTC TCCTGTACGTGTCTTCAAGGAA
DRP1 Human CTGCCTCAAATCGTCGTAGTG GAGGTCTCCGGGTGACAATTC
OPA1 Human TGTGAGGTCTGCCAGTCTTTA TGTCCTTAATTGGGGTCGTTG
FIS1 Human GTCCAAGAGCACGCAGTTTG ATGCCTTTACGGATGTCATCATT
β-Actin Human GCACCACACCTTCTACAATG TGCTTGCTGATCCACATCTG
4.11. Statistical Analysis
Parametric distribution of data was tested using the Kolmogorov–Smirnov test. Data are expressed
as mean ± standard error of mean (SEM). Statistical differences of parametric data were analyzed using
one-way ANOVA, while nonparametric data were analyzed with a Kruskal–Wallis test. p-values < 0.05
were considered to be statistically significant (* p < 0.05, ** p < 0.01, and *** p < 0.001); ns, not significant.
The data were analyzed using GraphPad Prism (v. 7.00; GraphPad Software Inc, La Jolla, USA).
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/4/1542/s1.
Figure S1: Islet and donor data; Table S1: The mRNA expressions of GPR41 and GPR43 in MIN6 cells.
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